1. Du, J. Ascorbic acid: Chemistry, biology and the treatment of cancer / J. Du, J. J. Cullen, G. R. Buettner // Biochim. Biophys. Acta. – 2012. – Vol. 1826, N 2. – P. 443–457. doi.org/10.1016/j.bbcan.2012.06.003
2. Cameron, E. Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer / E. Cameron, L. Pauling // Proc. Natl. Acad. Sci. USA. – 1976. – Vol. 73, N 10. – P. 3685–3689. doi.org/10.1073/ pnas.73.10.3685
3. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy A randomized double-blind comparison / C. G. Moertel [et al.] // N. Engl. J. Med. – 1985. – Vol. 312, N 3. – P. 137–141. doi.org/10.1056/nejm198501173120301
4. Vitamin C pharmacokinetics: implications for oral and intravenous use / S. J. Padayatty [et al.] // Ann. Intern. Med. – 2004. – Vol. 140, N 7. – P. 533–537. doi.org/10.7326/0003-4819-140-7-200404060-00010
5. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice / Q. Chen [et al.] // Proc. Natl. Acad. Sci. USA. – 2008. – Vol. 105, N 32. – P. 11105–11109. doi.org/10.1073/pnas.0804226105
6. Pharmacological ascorbic acid suppresses syngeneic tumor growth and metastases in hormone-refractory prostate cancer / H. B. Pollard [et al.] // In Vivo. – 2010. – Vol. 24. – P. 249–255.
7. Suh, J. Ascorbate does not act as a pro-oxidant towards lipids and proteins in human plasma exposed to redox-active transition metal ions and hydrogen peroxide / J. Suh, B. Zhu, B. Frei // Free Radic. Biol. Med. – 2003. – Vol. 34, N 10. – P. 1306–1314. doi.org/10.1016/s0891-5849(03)00147-3
8. Редокс-регуляция клеточной активности: концепции и механизмы / С. Н. Черенкевич [и др.] // Весці НАН Беларусі. Сер. біял. навук. – 2013. – № 1. – C. 92–108.
9. Martinovich, G. G. Effects of ascorbic acid on calcium signaling in tumor cells / G. G. Martinovich, I. V. Martinovich, S. N. Cherenkevich // Bull. Exp. Biol. Med. – 2009. – Vol. 147, N 4. – P. 469–472. doi.org/10.1007/s10517-009-0555-6
10. Redox regulation of calcium signaling in cancer cells by ascorbic acid involving the mitochondrial electron transport chain / G. G. Martinovich [et al.] // Journal of Biophysics. – 2012. – Vol. 2012. – Art. 921653. doi.org/10.1155/2012/921653
11. Martinovich, G. G. Redox regulation of cellular processes: a biophysical model and experiment / G. G. Martinovich, I. V. Martinovich, S. N. Cherenkevich // Biophysics. – 2011. – Vol. 56, N 3. – P. 444–451. doi.org/10.1134/s0006350911030171
12. Phenolic antioxidant TS-13 regulating ARE-driven genes induces tumor cell death by a mitochondria-dependent pathway / G. G. Martinovich [et al.] // Biophysics. – 2015. – Vol. 60, N 1. – P. 94–100. doi.org/10.1134/s0006350915010194
13. Thymoquinone, a biologically active component of Nigella sativa, induces mitochondrial production of reactive oxygen species and programmed death of tumor cells / G. G. Martinovich [et al.] // Biophysics. – 2016. – Vol. 61, N 6. – P. 963–970. doi.org/10.1134/s0006350916060154
14. Mazes of Nrf2 Regulation / N. K. Zenkov [et al.] // Biochemistry (Mosc). – 2017. – Vol. 82, N 5. – Р. 556–564. doi. org/10.1134/s0006297917050030
15. Dinkova-Kostova, A. T. Chemical structures of inducers of nicotinamide quinine oxidoreductase 1 (NQO1) / A. T. Dinkova-Kostova, J. W. Fahey, P. Talalay // Meth. Enzymol. – 2004. – Vol. 382. – P. 423–448. doi.org/10.1016/s0076-6879(04)82023-8
16. Ascorbic acid reduces HMGB1 secretion in lipopolysaccharide-activated RAW 264.7 cells and improves survival rate in septic mice by activation of Nrf2/HO-1 signals / S. R. Kim [et al.] // Biochemical Pharmacology. – 2015. – Vol. 95, N 4. – P. 279–289. doi.org/10.1016/j.bcp.2015.04.007
17. NADPH oxidase activity is required for endothelial cell proliferation and migration / M. Abid [et al.] // FEBS Letters. – 2000. – Vol. 486, N 3. – P. 252–256. doi.org/10.1016/s0014-5793(00)02305-x
